Fabry Disease Clinical Trials

A listing of Fabry Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
A Study of Replagal in Treatment-naïve Adults With Fabry Disease

In this study, adults with Fabry Disease who have not had any treatment for this condition will be treated with Replagal. The main aim of the study is to check if Replagal improves kidney

replacement therapy
deficit
gla gene
deficiency
alpha-galactosidase
  • 0 views
  • 09 May, 2022
  • 2 locations
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adult Males With Fabry Disease

is comprised of adult males with Fabry Disease.

angiokeratoma
hypertrophy
cornea verticillata
acroparesthesia
gene therapy
  • 18 views
  • 24 Apr, 2022
  • 5 locations
Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease

ascending doses of ST-920. ST-920 aims to provide stable, long-term production of α-Gal A at therapeutic levels in subjects with Fabry disease. The constant production of α-Gal A in humans should

angiokeratoma
cornea verticillata
anhidrosis
gene therapy
acroparesthesia
  • 114 views
  • 29 Apr, 2022
  • 12 locations
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Adult Participants With Fabry Disease (PERIDOT)

disease in adult participants with Fabry disease who are treatment-naïve or untreated for at least 6 months. Study visits will take place approximately every 3 months. The double

neuropathic pain
abdominal pain
  • 0 views
  • 22 Apr, 2022
Study of the Effects of Fabrazyme Treatment on Lactation and Infants

The study will last for up to 2 years (24 months). Full participation for both mother and infant is 24 months, full participation of mother and development of infant is 24 months, while full participation of mother and no infant participation is 6 months

agalsidase beta
fabrazyme
  • 75 views
  • 13 May, 2022
  • 2 locations
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Adult Participants With Fabry Disease (PERIDOT)

disease in adult participants with Fabry disease who are treatment-naïve or untreated for at least 6 months. Study visits will take place approximately every 3 months. The double

neuropathic pain
abdominal pain
  • 33 views
  • 13 May, 2022
Study of the Effects of Fabrazyme Treatment on Lactation and Infants

The study will last for up to 2 years (24 months). Full participation for both mother and infant is 24 months, full participation of mother and development of infant is 24 months, while full participation of mother and no infant participation is 6 months

agalsidase beta
fabrazyme
  • 0 views
  • 13 May, 2022
  • 2 locations
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease (CARAT)

alfa, agalsidase beta, or migalastat) to evaluate the effect of venglustat on left ventricular mass index (LVMI) in adult participants with Fabry disease and left ventricular hypertrophy.

hypertrophy
agalsidase alfa
migalastat
agalsidase beta
ventricular hypertrophy
  • 0 views
  • 06 May, 2022
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease (CARAT)

alfa, agalsidase beta, or migalastat) to evaluate the effect of venglustat on left ventricular mass index (LVMI) in adult participants with Fabry disease and left ventricular hypertrophy.

hypertrophy
agalsidase alfa
migalastat
agalsidase beta
ventricular hypertrophy
  • 0 views
  • 17 May, 2022
  • 1 location